Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
Laurus Labs (LAURUS IN)
Watchlist
61
Analysis
Health Care
•
India
Laurus Labs Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. It offers APIs for anti-retroviral and hepatitis C; and APIs in oncology and other therapeutic areas. .
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Suven Pharmaceuticals
•
14 Jan 2025 09:30
Suven Pharmaceuticals (SUVENPHA IN): M&A to Expand Technical Capabilities and Enhance Scale
Suven Pharmaceuticals strengthens position in high-growth markets such as ADCs and Oligonucleotides with acquisition of NJ Bio and Sapala Organics...
Tina Banerjee
Follow
376 Views
Share
bullish
•
Akums Drugs and Pharmaceuticals
•
16 Dec 2024 17:00
Akums Drugs and Pharmaceuticals: Limited Downside Is Seen, Long-Term Growth Story Intact
Akums Drugs shares are trading below IPO price post Q2FY25 results, but the company is well-positioned for long-term growth. Share price reaction...
Tina Banerjee
Follow
524 Views
Share
bullish
•
SAI Life Sciences
•
10 Dec 2024 09:37
SAI Life Sciences IPO- Growing and Profitable Business; Aggressive Pricing Limits Upside Potential
SAI Life Sciences intends to raise INR9.5B via India IPO. The IPO proceeds will be used for debt repayment. Marquee clientele and diverse portfolio...
Tina Banerjee
Follow
495 Views
Share
bearish
•
NTPC Ltd
•
26 Sep 2024 01:54
NIFTY Indices: Flows (Post Capping) At the Close Tomorrow; Round-Trip US$3.3bn
The next rebalance of the Nifty family of indices takes place at the close on 27 Sep. The round-trip trade is US$3.3bn and there are 13 stocks with...
Brian Freitas
Follow
605 Views
Share
bullish
•
Thematic (Sector/Industry)
•
10 Sep 2024 06:39
The US Biosecure Act: A Boon for Indian CDMO Players?
The Biosecure Act passed by the U.S. House could boost Indian CDMOs as alternative to Chinese biotechs by 2032, leading to potential growth...
Nimish Maheshwari
Follow
654 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.7
x